# Epitalon: Frequently Asked Questions

> Epitalon FAQ: 29 questions on mechanism, dosage, safety, telomerase, melatonin, cycling, and regulatory status — answered directly from the published literature, with citations. Epitalon research questions indexed.

## Q: What is epitalon?

Epitalon is a synthetic tetrapeptide — four amino acids: Ala-Glu-Asp-Gly (AEDG) — with a molecular weight of 390.35 Da. Developed by Vladimir Khavinson and colleagues as the purified active sequence of epithalamin, a bovine pineal gland extract. Also spelled "epithalon" in Western markets; both names refer to the same compound. Primary research applications: telomerase activation, telomere lengthening, pineal melatonin restoration. [1][21]

## Q: What are the benefits of epitalon according to research?

Animal studies report telomere lengthening (mean 33.3% increase in the 2025 systematic review [21]), increased telomerase activity, melatonin-normalized circadian function. Human observational data describe 1.6-1.8-fold all-cause mortality reductions in a 266-patient cohort followed for 6-8 years [9]. Human data lack randomized placebo controls. Independent replication in cell culture first published in 2025 [22].

## Q: What are the side effects of epitalon?

Published studies report no serious adverse effects. The 162-patient retinitis pigmentosa study and the 266-patient mortality cohort both reported no adverse events [9][16]. Long-term controlled human safety data do not exist. The 2025 systematic review calls for additional genotoxicity and long-term toxicity studies [21].

## Q: How does epitalon work?

Two documented pathways: (1) upregulates hTERT gene expression in somatic cells, restoring telomerase activity and enabling telomere elongation [1][2][22]; (2) stimulates AANAT — the rate-limiting enzyme in pineal melatonin synthesis — and its transcriptional activator pCREB [13]. A third pathway involves epigenetic chromatin decondensation in aged cells [15].

## Q: How long does epitalon take to work in research models?

In animal studies, measurable changes in telomere length observed after 10-day treatment courses, with effects persisting for weeks to months [21]. The biology requires cellular proliferation after telomerase activation.

## Q: Is epitalon safe to take?

Existing published studies report low toxicity and no serious adverse events. The longest human observations run 4-6 years without reported toxicity [9]. However, long-term controlled safety data meeting Western standards do not exist. The 2025 review calls for further genotoxicity characterization [21]. Not FDA approved; research chemical in US, EU, UK.

## Q: Should epitalon be taken in the morning or at night?

Research protocols vary. Some researchers administered evening courses given epitalon's proposed melatonin-modulating effect. No comparative human study has tested morning versus evening administration on any measured outcome.

## Q: What is the difference between epithalon and epitalon?

Same compound, two spellings. Epitalon is the Russian/scientific spelling. Epithalon is the Westernized commercial spelling. No chemical difference [21].

## Q: What is the difference between epithalon and epithalamin?

Epithalamin is a crude polypeptide fraction extracted from bovine pineal glands. Epitalon is the synthetic four-amino-acid sequence (Ala-Glu-Asp-Gly) identified as the putative active component. Epithalamin received limited clinical approval in Russia; epitalon has no equivalent regulatory approval in Western markets.

## Q: What is the recommended dosage of epitalon in research protocols?

Animal studies used 0.1-1 µg per mouse subcutaneous [4][8]. Russian clinical observations used 10-20 day parenteral cycles [9]. No consensus human dosing protocol exists.

## Q: How often should epitalon be cycled — once or twice a year?

Russian researchers typically ran one to two 10-day cycles per year [9]. The biological rationale: allow telomere changes to propagate across cell generations between treatment courses.

## Q: Why do researchers cycle epitalon instead of administering it continuously?

Telomere extension requires cellular proliferation after the triggering event. Continuous administration offers no incremental benefit once telomerase has been transiently activated [21].

## Q: Can epitalon be stacked with thymalin?

Yes, this was studied. Epitalon and thymalin in combination produced a 4.1-fold mortality reduction versus controls in a 266-patient cohort, compared to 1.6-1.8-fold for either peptide alone [9].

## Q: Does epitalon activate telomerase or work primarily through melatonin?

Both. Two independently documented pathways: direct hTERT upregulation [1][2][22] and separate AANAT/pCREB stimulation [13]. The 2025 systematic review treats these as converging rather than competing mechanisms [21].

## Q: How does epitalon affect melatonin production?

Restores age-related decline in pineal melatonin secretion by stimulating AANAT and pCREB [13]. In aged rhesus monkeys, epitalon significantly increased evening melatonin and normalized cortisol circadian rhythm [11]. Effects not observed in young animals.

## Q: Does synthetic epitalon suppress the natural peptide the body produces?

No suppression of endogenous pineal function has been reported. Not a hormone receptor agonist with negative feedback loops [21]. Bidirectional melatonin regulation observed is consistent with adaptive modulation [12].

## Q: Is it safe to take epitalon long-term?

The longest published human observations run 4-6 years with no toxicity reported [9]. The 2025 review calls for further genotoxicity characterization [21]. Absence of reported adverse events is not equivalent to controlled long-term safety surveillance.

## Q: Does epitalon affect cancer risk through telomerase activation?

Existing rodent carcinogenesis studies found no tumor promotion and several showed antitumor effects [5][6][7][8]. However, the 2025 Biogerontology study found epitalon elevated hTERT in cancer cell lines and activated ALT — 10-fold ALT increase in 21NT cells [22]. The telomerase-cancer concern is not resolved by current data.

## Q: How do you store epitalon vials once reconstituted?

Reconstitute with bacteriostatic water, store at 2-8°C, use within 2-4 weeks. Freeze-thaw cycling degrades peptide integrity. Lyophilized powder stable at -20°C.

## Q: Is there a difference between subcutaneous and intramuscular injection?

Most published protocols use subcutaneous injection. No comparative bioavailability study specific to epitalon has been published. An intranasal route was studied in a rat neocortex study [18] but not used in aging or telomere studies.

## Q: Does epitalon have effects on skin aging, wrinkles, or hair graying?

Rodent studies noted reduced lipofuscin accumulation and preservation of coat quality [21]. No controlled human trials measuring skin aging, wrinkle depth, or hair graying have been published.

## Q: How is epitalon different from a standard telomerase supplement?

Epitalon is a peptide administered parenterally that directly regulates hTERT gene expression — a mechanistically distinct approach from oral telomerase supplements like cycloastragenol [22]. Comparative efficacy data do not exist in indexed literature.

## Q: Does epitalon have effects on sleep quality?

Animal and limited human observational data suggest epitalon normalizes age-related decline in melatonin amplitude, associated with improved deep sleep architecture [10][11]. This is mechanistically downstream of pineal activation.

## Q: Has epitalon been studied in human clinical trials?

Several Russian clinical investigations were conducted. Most lacked placebo-controlled randomized designs meeting FDA/EMA standards. No Phase II/III RCTs on ClinicalTrials.gov. Most extensive follow-up: 266 patients, 6-8 years [9]. 162-patient retinitis pigmentosa study: 90% positive results [16].

## Q: What is epitalon used for in research?

Telomerase activation and telomere length maintenance; neuroendocrine restoration; antioxidant biomarker improvement; longevity investigation in animal models; retinal biology; reproductive cell biology. [1][16][17][21][23][24]

## Q: What is the regulatory status of epitalon?

Not FDA approved. Research chemical in US, EU, UK. In Russia, epithalamin (the parent extract) has limited clinical approval; synthetic epitalon does not have equivalent Western regulatory approval. No WADA prohibition specifically covers epitalon as of the literature review date [21].

## Q: Do results from epitalon research persist after the treatment cycle ends?

Some animal studies report sustained changes in telomere length and antioxidant markers for months following a single treatment course [21]. Telomerase-extended telomeres persist through subsequent cell divisions independently of the triggering peptide.

## Q: How does epitalon differ from BPC-157 or TB-500?

Epitalon targets the telomere-telomerase and pineal-melatonin axes — its evidence base is primarily in aging and longevity models. BPC-157 is a 15-amino-acid gastric peptide with a tissue-repair evidence base. TB-500 has an actin polymerization and wound-healing evidence base. The three compounds address different biological systems with no published cross-comparison data.

## Q: What is epitalon's half-life?

No formal pharmacokinetic study characterizing epitalon's half-life in plasma has been published. As a tetrapeptide (390.35 Da), it is subject to rapid proteolytic degradation — typically minutes to hours for unmodified short peptides.

## References

[1] PMID 12937682 | [2] PMID 15455129 | [4] PMID 14501183 | [5] PMID 12049808 | [6] PMID 12964022 | [7] PMID 12209581 | [8] PMID 16634527 | [9] PMID 14523363 | [10] PMID 17969590 | [11] PMID 11524632 | [12] PMID 15452611 | [13] PMID 22816096 | [15] PMID 14647006 | [16] PMID 12195242 | [17] PMID 35413689 | [18] PMID 17955380 | [21] PMID 40141333 | [22] PMID 40908429 | [23] PMID 39788414 | [24] PMID 40493162

---

Twenty-five years of epitalon findings — counted, cited, and indexed as a research record. Not a clinic.
